1. Home
  2. SUPN vs MSGE Comparison

SUPN vs MSGE Comparison

Compare SUPN & MSGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • MSGE
  • Stock Information
  • Founded
  • SUPN 2005
  • MSGE 2020
  • Country
  • SUPN United States
  • MSGE United States
  • Employees
  • SUPN N/A
  • MSGE N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • MSGE Services-Misc. Amusement & Recreation
  • Sector
  • SUPN Health Care
  • MSGE Consumer Discretionary
  • Exchange
  • SUPN Nasdaq
  • MSGE Nasdaq
  • Market Cap
  • SUPN 2.0B
  • MSGE 1.9B
  • IPO Year
  • SUPN 2012
  • MSGE N/A
  • Fundamental
  • Price
  • SUPN $42.00
  • MSGE $37.60
  • Analyst Decision
  • SUPN Buy
  • MSGE Strong Buy
  • Analyst Count
  • SUPN 2
  • MSGE 6
  • Target Price
  • SUPN $41.00
  • MSGE $49.83
  • AVG Volume (30 Days)
  • SUPN 1.0M
  • MSGE 319.0K
  • Earning Date
  • SUPN 08-05-2025
  • MSGE 08-13-2025
  • Dividend Yield
  • SUPN N/A
  • MSGE N/A
  • EPS Growth
  • SUPN 1411.53
  • MSGE N/A
  • EPS
  • SUPN 1.14
  • MSGE 0.77
  • Revenue
  • SUPN $665,125,000.00
  • MSGE $942,734,000.00
  • Revenue This Year
  • SUPN N/A
  • MSGE $8.62
  • Revenue Next Year
  • SUPN $15.74
  • MSGE $4.69
  • P/E Ratio
  • SUPN $37.58
  • MSGE $47.68
  • Revenue Growth
  • SUPN 5.55
  • MSGE N/A
  • 52 Week Low
  • SUPN $29.16
  • MSGE $28.29
  • 52 Week High
  • SUPN $43.73
  • MSGE $44.14
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 69.63
  • MSGE 46.55
  • Support Level
  • SUPN $40.26
  • MSGE $35.31
  • Resistance Level
  • SUPN $43.73
  • MSGE $40.50
  • Average True Range (ATR)
  • SUPN 1.80
  • MSGE 1.24
  • MACD
  • SUPN 0.31
  • MSGE -0.16
  • Stochastic Oscillator
  • SUPN 84.13
  • MSGE 44.12

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About MSGE Madison Square Garden Entertainment Corp.

Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.

Share on Social Networks: